OBJECTIVES: To demonstrate the value of routine, basic sexually transmitted infection (STI) screening at enrolment into an HIV-1 vaccine feasibility cohort study and to highlight the importance of soliciting a history of receptive anal intercourse (RAI) in adults identified as "high risk". METHODS: Routine STI screening was offered to adults at high risk of HIV-1 upon enrolment into a cohort study in preparation for HIV-1 vaccine trials. Risk behaviours and STI prevalence were summarised and the value of microscopy assessed. Associations between prevalent HIV-1 infection and RAI or prevalent STI were evaluated with multiple logistic regression. RESULTS: Participants had a high burden of untreated STI. Symptom-directed management would have missed 67% of urethritis cases in men and 59% of cervicitis cases in women. RAI was reported by 36% of male and 18% of female participants. RAI was strongly associated with HIV-1 in men (adjusted odds ratio (aOR) 3.8; 95% CI 2.0 to 6.9) and independently associated with syphilis in women (aOR 12.9; 95% CI 3.4 to 48.7). CONCLUSIONS: High-risk adults recruited for HIV-1 prevention trials carry a high STI burden. Symptom-directed treatment may miss many cases and simple laboratory-based screening can be done with little cost. Risk assessment should include questions about anal intercourse and whether condoms were used. STI screening, including specific assessment for anorectal disease, should be offered in African research settings recruiting participants at high risk of HIV-1 acquisition.
OBJECTIVES: To demonstrate the value of routine, basic sexually transmitted infection (STI) screening at enrolment into an HIV-1 vaccine feasibility cohort study and to highlight the importance of soliciting a history of receptive anal intercourse (RAI) in adults identified as "high risk". METHODS: Routine STI screening was offered to adults at high risk of HIV-1 upon enrolment into a cohort study in preparation for HIV-1 vaccine trials. Risk behaviours and STI prevalence were summarised and the value of microscopy assessed. Associations between prevalent HIV-1 infection and RAI or prevalent STI were evaluated with multiple logistic regression. RESULTS:Participants had a high burden of untreated STI. Symptom-directed management would have missed 67% of urethritis cases in men and 59% of cervicitis cases in women. RAI was reported by 36% of male and 18% of female participants. RAI was strongly associated with HIV-1 in men (adjusted odds ratio (aOR) 3.8; 95% CI 2.0 to 6.9) and independently associated with syphilis in women (aOR 12.9; 95% CI 3.4 to 48.7). CONCLUSIONS: High-risk adults recruited for HIV-1 prevention trials carry a high STI burden. Symptom-directed treatment may miss many cases and simple laboratory-based screening can be done with little cost. Risk assessment should include questions about anal intercourse and whether condoms were used. STI screening, including specific assessment for anorectal disease, should be offered in African research settings recruiting participants at high risk of HIV-1 acquisition.
Authors: Robert C Bailey; Stephen Moses; Corette B Parker; Kawango Agot; Ian Maclean; John N Krieger; Carolyn F M Williams; Richard T Campbell; Jeckoniah O Ndinya-Achola Journal: Lancet Date: 2007-02-24 Impact factor: 79.321
Authors: Eduard J Sanders; Susan M Graham; Haile S Okuku; Elise M van der Elst; Allan Muhaari; Alun Davies; Norbert Peshu; Matthew Price; R Scott McClelland; Adrian D Smith Journal: AIDS Date: 2007-11-30 Impact factor: 4.177
Authors: Phoebe Kajubi; Moses R Kamya; H Fisher Raymond; Sanny Chen; George W Rutherford; Jeffrey S Mandel; Willi McFarland Journal: AIDS Behav Date: 2007-10-30
Authors: Nancy S Padian; Ariane van der Straten; Gita Ramjee; Tsungai Chipato; Guy de Bruyn; Kelly Blanchard; Stephen Shiboski; Elizabeth T Montgomery; Heidi Fancher; Helen Cheng; Michael Rosenblum; Mark van der Laan; Nicholas Jewell; James McIntyre Journal: Lancet Date: 2007-07-21 Impact factor: 79.321
Authors: Scott Geibel; Elisabeth M van der Elst; Nzioki King'ola; Stanley Luchters; Alun Davies; Esther M Getambu; Norbert Peshu; Susan M Graham; R Scott McClelland; Eduard J Sanders Journal: AIDS Date: 2007-06-19 Impact factor: 4.177
Authors: Rebecca F Baggaley; Dobromir Dimitrov; Branwen N Owen; Michael Pickles; Ailsa R Butler; Ben Masse; Marie-Claude Boily Journal: Am J Reprod Immunol Date: 2012-12-24 Impact factor: 3.886
Authors: Eduard J Sanders; Haile S Okuku; Adrian D Smith; Mary Mwangome; Elizabeth Wahome; Gregory Fegan; Norbert Peshu; Elisabeth M van der Elst; Matthew A Price; R Scott McClelland; Susan M Graham Journal: AIDS Date: 2013-01-28 Impact factor: 4.177
Authors: Cecily Banura; Florence M Mirembe; Jackson Orem; Anthony K Mbonye; Simon Kasasa; Edward K Mbidde Journal: Infect Agent Cancer Date: 2013-07-10 Impact factor: 2.965
Authors: Miriam Taegtmeyer; Alun Davies; Mary Mwangome; Elisabeth M van der Elst; Susan M Graham; Matt A Price; Eduard J Sanders Journal: PLoS One Date: 2013-06-07 Impact factor: 3.240
Authors: Stefan Baral; Gift Trapence; Felistus Motimedi; Eric Umar; Scholastika Iipinge; Friedel Dausab; Chris Beyrer Journal: PLoS One Date: 2009-03-26 Impact factor: 3.240
Authors: Elisabeth M van der Elst; Haile Selassie Okuku; Phellister Nakamya; Allan Muhaari; Alun Davies; R Scott McClelland; Matthew A Price; Adrian D Smith; Susan M Graham; Eduard J Sanders Journal: PLoS One Date: 2009-05-01 Impact factor: 3.240
Authors: Peter M Mugo; Sarah Duncan; Samuel W Mwaniki; Alexander N Thiong'o; Evanson Gichuru; Haile Selassie Okuku; Elise M van der Elst; Adrian D Smith; Susan M Graham; Eduard J Sanders Journal: Sex Transm Infect Date: 2013-05-22 Impact factor: 3.519
Authors: Angela Kelly-Hanku; Andrew Vallely; Wing Young Nicola Man; David Wilson; Greg Law; Richard Gray Journal: BMC Public Health Date: 2013-12-01 Impact factor: 3.295